Vaccination, booster shots remain top strategy in protecting long-term care residents, workers
By
Kimberly Bonvissuto
Nov 18, 2021
COVID-19 is not done with us. LeadingAge Senior Vice President of Policy Ruth Katz opened Wednesday’s membership update call with news that several states are seeing increasing coronavirus cases. Connecticut,...
Pfizer asks FDA to approve booster shots for all U.S. adults
Nov 10, 2021
With its application, the company included early results of a study that involved 10,000 people.
Vaccine mandates not scaring workers away, Sabra CEO says
By
Lois A. Bowers
Nov 05, 2021
Labor issues are slowing the senior living and care industry’s recovery from the coronavirus pandemic, but operators should not spend much time worrying that they will lose workers if they implement...
Long-term care workers must be vaccinated by Jan. 4 under OSHA, CMS rules
By
Kathleen Steele Gaivin
Nov 05, 2021
Jan. 4 is the COVID-19 vaccination deadline for employees in companies that have 100 or more workers, as well as for employees of long-term care facilities that participate in Medicare and Medicaid, according...
States, courts take actions that complicate vaccine mandate effects
By
Kathleen Steele Gaivin
Nov 01, 2021
So far, courts across the country—all the way up to the U.S. Supreme Court—have sided with state governments on imposed vaccine requirements. The justices declined Friday to even hear a case challenging...
All states must comply with forthcoming COVID vaccine mandate, former OSHA official says
By
Kathleen Steele Gaivin
Oct 29, 2021
Individual states do not have the authority to opt out of the emergency temporary standard on workplace COVID-19 vaccines and testing expected to be released soon by the Department of Labor’s Occupational...
Potential safety concern for Guillain-Barré syndrome ID’d for Ad26.COV2.S
Oct 18, 2021
Receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine is associated with a potential small, but statistically significant, safety concern for Guillain-Barré syndrome (GBS), according...
FDA panel recommends approval of Johnson & Johnson booster shot
Oct 15, 2021
The booster shot is recommended for anyone 18 years and older, to be given at least two months after the first dose.
FDA expert panel to weigh approval of Moderna, Johnson & Johnson booster shots
Oct 13, 2021
The panel will consider whether a third Moderna shot should contain half the original dose, as well as the best timing for a second shot of single-dose J&J vaccine.
Senior living communities adopt regional approach to staff COVID-19 vaccine mandates
By
Kimberly Bonvissuto
Sep 20, 2021
Eight Lancaster, PA, senior living communities have banded together in announcing a COVID-19 staff vaccination requirement in the “best interest of everyone in our individual communities, as well as...